Yahoo Web Search

  1. Web results

  2. C. R. Bard - Wikipedia

    en.wikipedia.org/wiki/C._R._BardCached

    C. R. Bard, Inc., now branded simply as Bard, headquartered in Murray Hill, New Jersey, USA, is a leading multinational developer, manufacturer, ...

  3. About C. R. Bard, Inc. | Bard

    www.crbard.com/en-US/About-CRBardCached

    C. R. Bard, Inc. is a multinational developer, manufacturer and marketer of medical devices in vascular, urology, oncology and surgical specialty areas. Get to know us.

  4. Stock analysis for CR Bard Inc (BCR) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

  5. Bard Medical

    www.bardmedical.com/productsCached

    Bard Medical is excited to announce the acquisition of Rochester Medical Bard Medical and Rochester Medical are coming together, combining quality, innovative products and services

  6. C. R. Bard, Inc. (NYSE:BCR) :: Law360

    www.law360.com/companies/c-r-bard-inc

    The latest litigation news, cases and dockets involving the company C. R. Bard, Inc. (NYSE:BCR)

  7. C.R. Bard, Inc. 7/13/15 - Food and Drug Administration

    www.fda.gov/ICECI/EnforcementActions/Warning...Cached

    WARNING LETTER. VIA UNITED PARCEL SERVICE SIGNATURE REQUIRED. July 13, 2015 . W/L # 27-15 . Timothy M. Ring Chairman and Chief Executive Officer C.R. Bard Inc.

  8. Working at Bard | Glassdoor

    www.glassdoor.com/Overview/Working-at-Bard-EI_IE...Cached

    C. R. Bard, Inc. is a leading multinational developer, manufacturer, and marketer of innovative, life-enhancing medical technologies in the product fields of:

  9. C. R. BARD, INC. - SEC.gov

    www.sec.gov/.../9892/000000989203000076/bard2002.pdf

    In 1923, the company was incorporated as C. R. Bard, Inc. and distributed an assortment of urological and surgical products.

  10. C.R. Bard Inc. to Pay U.S. $48.26 Million to Resolve False ...

    www.justice.gov/opa/pr/cr-bard-inc-pay-us-4826...Cached

    C.R. Bard Inc. has agreed to pay the United States $48.26 million to resolve claims that it knowingly caused false claims to be submitted to the Medicare program for brachytherapy seeds used to treat prostate cancer in violation of the False Claims Act.